Clinical Trial

Published on 21 Apr 2023

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia

in Neuropharmacology

Xiaoe Lang
Xiaocui Zang
Feng Yu
Meihong Xiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1166507

11,409 views
1 citation

Original Research

Published on 21 Apr 2023

Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment

in Neuropharmacology

Yunjie Wang
Zhaofeng Liu
Jing Lu
Wenyan Wang
Lin Wang
Yifei Yang
Hongbo Wang
Liang Ye
Jianzhao Zhang
Jingwei Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161964

4,970 views
3 citations

Original Research

Published on 20 Apr 2023

Fluoxetine degrades luminance perceptual thresholds while enhancing motivation and reward sensitivity

in Neuropharmacology

Maëva Gacoin
Suliann Ben Hamed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103999

3,807 views
2 citations

Review

Published on 20 Apr 2023

Bulbospinal nociceptive ON and OFF cells related neural circuits and transmitters

in Neuropharmacology

Bingxue Peng
Yingfu Jiao
Yunchun Zhang
Shian Li
Sihan Chen
Saihong Xu
Po Gao
Yinghui Fan
Weifeng Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159753

5,266 views
8 citations

Original Research

Published on 20 Apr 2023

Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders

in Neuropharmacology

Martina Tallarico
Antonio Leo
Emilio Russo
Rita Citraro
Ernesto Palma
Giovambattista De Sarro

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155729

3,367 views
4 citations

Review

Published on 13 Apr 2023

Targeting ferroptosis as novel therapeutic approaches for epilepsy

in Neuropharmacology

Yuzi Jin
Lei Ren
Xiaoqing Jing
Hongquan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185071

5,120 views
10 citations

Editorial

Published on 12 Apr 2023

Editorial: Women in neuropharmacology: 2021

in Neuropharmacology

Divya Vohora
Nidhi Agarwal

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1198876

2,873 views

Original Research

Published on 12 Apr 2023

Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia

in Neuropharmacology

Ashley Wagner
Marcus Pehar
Zhimin Yan
Marianna Kulka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102465

26,635 views
4 citations

Editorial

Published on 12 Apr 2023

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II

in Neuropharmacology

Ana Rita Vaz
Ana Sofia Falcão
Valle Palomo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1198151

2,220 views

Review

Published on 06 Apr 2023

Neurotrophic basis to the pathogenesis of depression and phytotherapy

in Neuropharmacology

Huiqin Wang
Yantao Yang
Gang Pei
Zhenzhen Wang
Naihong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1182666

4,861 views
11 citations

Review

Published on 03 Apr 2023

Myelin sheath injury and repairment after subarachnoid hemorrhage

in Neuropharmacology

Mao Chen
Peiwen Guo
Xufang Ru
Yujie Chen
Shilun Zuo
Hua Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145605

4,155 views
2 citations

Editorial

Published on 31 Mar 2023

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II

in Neuropharmacology

Marta P. Pereira
Borja García-Bueno
Javier R. Caso

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191907

2,967 views

Original Research

Published on 30 Mar 2023

Baicalein-corrected gut microbiota may underlie the amelioration of memory and cognitive deficits in APP/PS1 mice

in Neuropharmacology

Jing Shi
Jie Chen
Xinyun Xie
Yuanyuan Li
Wenjing Ye
Jianbiao Yao
Xiangnan Zhang
Tianyuan Zhang
Jianqing Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1132857

4,678 views
4 citations

Review

Published on 30 Mar 2023

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies

in Neuropharmacology

Elisabet Jerlhag

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1063033

15,181 views
24 citations

Original Research

Published on 29 Mar 2023

Astrocytes underlie a faster-onset antidepressant effect of hypidone hydrochloride (YL-0919)

in Neuropharmacology

Jin-Feng Li
Wen-Yu Hu
Hai-Xia Chang
Jin-Hao Bao
Xiang-Xi Kong
Hui Ma
Yun-Feng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1175938

3,868 views
6 citations

Original Research

Published on 29 Mar 2023

Influenza vaccine is able to prevent neuroinflammation triggered by H7N7 IAV infection

in Neuropharmacology

Luisa Demuth
Melanie Ohm
Kristin Michaelsen-Preusse
Kai Schulze
Peggy Riese
Carlos A. Guzmán
Martin Korte
Shirin Hosseini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1142639

4,873 views
5 citations

Navigation group

Articles

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia

Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment

Fluoxetine degrades luminance perceptual thresholds while enhancing motivation and reward sensitivity

Bulbospinal nociceptive ON and OFF cells related neural circuits and transmitters

Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders

Targeting ferroptosis as novel therapeutic approaches for epilepsy

Editorial: Women in neuropharmacology: 2021

Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II

Neurotrophic basis to the pathogenesis of depression and phytotherapy

Myelin sheath injury and repairment after subarachnoid hemorrhage

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II

Baicalein-corrected gut microbiota may underlie the amelioration of memory and cognitive deficits in APP/PS1 mice

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies

Astrocytes underlie a faster-onset antidepressant effect of hypidone hydrochloride (YL-0919)

Influenza vaccine is able to prevent neuroinflammation triggered by H7N7 IAV infection